Viberzi Potential Pancreatitis or Death Risk for Certain Patients
Viberzi Potential Pancreatitis Injury Lawsuits. The U.S. Food and Drug Administration (FDA) approved Viberzi, a treatment for irritable bowel syndrome with the primary symptom, diarrhea, in May 2015. There have been at least 120 reports to the FDA Adverse Event Reporting System (FAERS) of pancreatitis or death, since that … [Read more...] about Viberzi Potential Pancreatitis or Death Risk for Certain Patients
Viberzi Linked to Two Deaths
Allergan’s Viberzi Increase Risk Of Pancreatitis. After the death of two patients, both without a gallbladder, who had been taking Allergan's irritable bowel drug Viberzi, the U.S. Food and Drug Administration (FDA) warned about the increased risk of severe pancreatitis in such patients. The FDA is warning in a Drug Safety … [Read more...] about Viberzi Linked to Two Deaths
